<p>Abbreviations: ARCL: AIDS Reference Center Leuven, CRF: Circulating recombinant form, ESAR: European Society for Translational Antiviral Research, IVDU: intravenous drug user, NRTI: nucleoside reverse transcriptase inhibitors, NNRTI: non-nucleoside reverse transcriptase inhibitors, MSM: men who have sex with men, MTCT: mother to child transmission, PI: protease inhibitors,<sup>†</sup>Patient ID includes patients of the Leuven cohort (bold and italics), ESAR controls and accession numbers of NCBI database *Control sequences have available year of sampling. <sup>‡</sup>Control sequences with year of diagnosis available. <sup>§</sup>Sequences were also included when the patient was on antiretroviral treatment.</p
BACKGROUND: Human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) can compro...
PMID: 25849352 WOS:000354825700001Regional and subtype-specific mutational patterns of HIV-1 transmi...
<p>The prevalences are detached according to A) drug class; B) HIV-1 variant; C) origin of the patie...
We aimed to study epidemic trends and predictors for transmitted drug resistance (TDR) in our region...
Transmitted drug resistance (TDR) influencing nonnucleoside reverse transcriptase inhibitor (NNRTI) ...
We aimed to study epidemic trends and predictors for transmitted drug resistance (TDR) in our region...
<p>(<b>A</b>) Trends of prevalence of TDR (percentage) and the 95% confidence intervals (light shadi...
OBJECTIVES: To monitor HIV-1 transmitted drug resistance (TDR) in a well defined urban area with lar...
OBJECTIVES: To monitor HIV-1 transmitted drug resistance (TDR) in a well defined urban area with lar...
Background. Human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) can compro...
<p>Abbreviations: FPR, False Positive Rate; MSM, Men who have Sex with Men; MSMW, Men who have Sex w...
Human immunodeficiency virus type 1 (HIV-1) genomes often carry one or more mutations associated wit...
Idue where variability was found in ARV-naïve patients. (N): number of samples from naïve patients h...
Background. Human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) can compro...
Transmitted drug resistance (TDR) is a clinical and epidemiological problem because it may contribut...
BACKGROUND: Human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) can compro...
PMID: 25849352 WOS:000354825700001Regional and subtype-specific mutational patterns of HIV-1 transmi...
<p>The prevalences are detached according to A) drug class; B) HIV-1 variant; C) origin of the patie...
We aimed to study epidemic trends and predictors for transmitted drug resistance (TDR) in our region...
Transmitted drug resistance (TDR) influencing nonnucleoside reverse transcriptase inhibitor (NNRTI) ...
We aimed to study epidemic trends and predictors for transmitted drug resistance (TDR) in our region...
<p>(<b>A</b>) Trends of prevalence of TDR (percentage) and the 95% confidence intervals (light shadi...
OBJECTIVES: To monitor HIV-1 transmitted drug resistance (TDR) in a well defined urban area with lar...
OBJECTIVES: To monitor HIV-1 transmitted drug resistance (TDR) in a well defined urban area with lar...
Background. Human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) can compro...
<p>Abbreviations: FPR, False Positive Rate; MSM, Men who have Sex with Men; MSMW, Men who have Sex w...
Human immunodeficiency virus type 1 (HIV-1) genomes often carry one or more mutations associated wit...
Idue where variability was found in ARV-naïve patients. (N): number of samples from naïve patients h...
Background. Human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) can compro...
Transmitted drug resistance (TDR) is a clinical and epidemiological problem because it may contribut...
BACKGROUND: Human immunodeficiency virus type 1 (HIV-1) transmitted drug resistance (TDR) can compro...
PMID: 25849352 WOS:000354825700001Regional and subtype-specific mutational patterns of HIV-1 transmi...
<p>The prevalences are detached according to A) drug class; B) HIV-1 variant; C) origin of the patie...